MIC Values of Voriconazole Are Predictive of Treatment Results in Murine Infections by Aspergillus terreus Species Complex
Author(s) -
Valentina Salas,
Francisco Pastor,
Deanna A. Sutton,
Enrique Calvo,
Emilio Mayayo,
Annette W. Fothergill,
Michael G. Rinaldi,
Josep Guarro
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01436-12
Subject(s) - aspergillus terreus , voriconazole , galactomannan , aspergillus , aspergillosis , microbiology and biotechnology , biology , predictive value , medicine , immunology , antifungal
We evaluated the efficacy of voriconazole against nine strains ofAspergillus terreus with different MICs (0.12 to 4 μg/ml) by using a murine model. Markers of efficacy included survival, tissue burden, galactomannan antigenemia, and drug serum levels. Voriconazole was especially effective in prolonging survival and reducing the fungal load in infections by strains that showed MICs that were less than or equal to the epidemiological cutoff value (1 μg/ml).In vitro data might be useful for predicting the outcome ofA. terreus infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom